Literature DB >> 23670889

Association of dopamine D2 receptor and leptin receptor genes with clinically severe obesity.

Catherine L Carpenter1, Angela M Wong, Zhaoping Li, Ernest P Noble, David Heber.   

Abstract

OBJECTIVE: The brain reward circuits that promote drug abuse may also be involved in pleasure seeking behavior and food cravings observed in severely obese subjects. Drug addiction polymorphisms such as the TaqI A1 allele of the dopamine D2 receptor (DRD2) are associated with cocaine, alcohol, and opioid use, but few studies have linked DRD2 to food craving. Other genes such as the leptin receptor gene (LEPR) and mu-opioid receptor gene (OPRM1) that affect appetite and pleasure centers in the brain may also influence food addiction and obesity. The three genes together may function synergistically. DESIGN AND METHODS: To evaluate associations between candidate genes, food craving, overeating, and BMI, we administered questionnaires including Power of Food Scale and Food Craving Inventory, conducted anthropometric measures, and collected blood from patients undergoing weight-loss treatment. Questionnaires and DNA specimens were collected for 80 participants.
RESULTS: Participants were mostly female (74%) and Caucasian (79%), with an average age of 53 years old. Mean BMI for all participants was 43 kg/m2 and was significantly associated in a linear fashion with Food Craving Inventory scores (P=0.0001) and Power of Food (P=0.02). The DRD2 TaqI A1 allele was significantly associated with BMI (P=0.04), while LEPR Lys109Arg and OPRM1 A118G variants were not. We stratified DRD2 by LEPR and OPRM1, and observed a significant interaction (P = 0.04) between DRD2 and LEPR, and a marginally significant interaction (P=0.06) between DRD2 and OPRM1.
CONCLUSION: Genes associated with addictive behavior and appetite control may therefore, in combination, markedly influence development of clinically severe obesity.
Copyright © 2013 The Obesity Society.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23670889      PMCID: PMC7081169          DOI: 10.1002/oby.20202

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  39 in total

1.  Enhanced resting activity of the oral somatosensory cortex in obese subjects.

Authors:  Gene-Jack Wang; Nora D Volkow; Christoph Felder; Joanna S Fowler; Alejandro V Levy; Naomi R Pappas; Christopher T Wong; Wei Zhu; Noelwah Netusil
Journal:  Neuroreport       Date:  2002-07-02       Impact factor: 1.837

2.  On dopamine, D2 receptor, and Taq1A polymorphism in obesity and anorexia.

Authors:  Sergueï O Fetissov; Michael M Meguid
Journal:  Nutrition       Date:  2009-02       Impact factor: 4.008

3.  Brain dopamine and obesity.

Authors:  G J Wang; N D Volkow; J Logan; N R Pappas; C T Wong; W Zhu; N Netusil; J S Fowler
Journal:  Lancet       Date:  2001-02-03       Impact factor: 79.321

4.  DRD2 genetic variation in relation to smoking and obesity in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.

Authors:  Lindsay M Morton; Sophia S Wang; Andrew W Bergen; Nilanjan Chatterjee; Paul Kvale; Robert Welch; Meredith Yeager; Richard B Hayes; Stephen J Chanock; Neil E Caporaso
Journal:  Pharmacogenet Genomics       Date:  2006-12       Impact factor: 2.089

5.  Haplotype spanning TTC12 and ANKK1, flanked by the DRD2 and NCAM1 loci, is strongly associated to nicotine dependence in two distinct American populations.

Authors:  Joel Gelernter; Yi Yu; Roger Weiss; Kathleen Brady; Carolien Panhuysen; Bao-Zhu Yang; Henry R Kranzler; Lindsay Farrer
Journal:  Hum Mol Genet       Date:  2006-11-03       Impact factor: 6.150

6.  Inhibiting food reward: delay discounting, food reward sensitivity, and palatable food intake in overweight and obese women.

Authors:  Bradley M Appelhans; Kathleen Woolf; Sherry L Pagoto; Kristin L Schneider; Matthew C Whited; Rebecca Liebman
Journal:  Obesity (Silver Spring)       Date:  2011-04-07       Impact factor: 5.002

7.  Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction.

Authors:  C Bond; K S LaForge; M Tian; D Melia; S Zhang; L Borg; J Gong; J Schluger; J A Strong; S M Leal; J A Tischfield; M J Kreek; L Yu
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

8.  Relation between obesity and blunted striatal response to food is moderated by TaqIA A1 allele.

Authors:  E Stice; S Spoor; C Bohon; D M Small
Journal:  Science       Date:  2008-10-17       Impact factor: 47.728

9.  Food reinforcement, the dopamine D2 receptor genotype, and energy intake in obese and nonobese humans.

Authors:  Leonard H Epstein; Jennifer L Temple; Brad J Neaderhiser; Robbert J Salis; Richard W Erbe; John J Leddy
Journal:  Behav Neurosci       Date:  2007-10       Impact factor: 1.912

10.  Diagnostic validity of the drug abuse screening test in the assessment of DSM-III drug disorders.

Authors:  D R Gavin; H E Ross; H A Skinner
Journal:  Br J Addict       Date:  1989-03
View more
  33 in total

1.  Pre-existing differences in motivation for food and sensitivity to cocaine-induced locomotion in obesity-prone rats.

Authors:  Peter J Vollbrecht; Cameron W Nobile; Aaron M Chadderdon; Emily M Jutkiewicz; Carrie R Ferrario
Journal:  Physiol Behav       Date:  2015-09-28

Review 2.  Genetic Similarities between Compulsive Overeating and Addiction Phenotypes: A Case for "Food Addiction"?

Authors:  Nina Carlier; Victoria S Marshe; Jana Cmorejova; Caroline Davis; Daniel J Müller
Journal:  Curr Psychiatry Rep       Date:  2015-12       Impact factor: 5.285

Review 3.  Linking obesity-induced leptin-signaling pathways to common endocrine-related cancers in women.

Authors:  Eunice Nyasani; Iqbal Munir; Mia Perez; Kimberly Payne; Salma Khan
Journal:  Endocrine       Date:  2018-09-14       Impact factor: 3.633

4.  Basal Ganglia Dysfunction Contributes to Physical Inactivity in Obesity.

Authors:  Danielle M Friend; Kavya Devarakonda; Timothy J O'Neal; Miguel Skirzewski; Ioannis Papazoglou; Alanna R Kaplan; Jeih-San Liow; Juen Guo; Sushil G Rane; Marcelo Rubinstein; Veronica A Alvarez; Kevin D Hall; Alexxai V Kravitz
Journal:  Cell Metab       Date:  2016-12-29       Impact factor: 27.287

5.  Early-Life Adversity and Blunted Stress Reactivity as Predictors of Alcohol and Drug use in Persons With COMT (rs4680) Val158Met Genotypes.

Authors:  William R Lovallo; Andrew J Cohoon; Kristen H Sorocco; Andrea S Vincent; Ashley Acheson; Colin A Hodgkinson; David Goldman
Journal:  Alcohol Clin Exp Res       Date:  2019-05-31       Impact factor: 3.455

Review 6.  Hormonal and neural mechanisms of food reward, eating behaviour and obesity.

Authors:  Susan Murray; Alastair Tulloch; Mark S Gold; Nicole M Avena
Journal:  Nat Rev Endocrinol       Date:  2014-06-24       Impact factor: 43.330

7.  Dopamine receptor D2 polymorphism is associated with alleviation of obesity after 8-year follow-up: a retrospective cohort study in obese Chinese children and adolescents.

Authors:  Jian-Fang Zhu; Lian-Hui Chen; Ke Yuan; Li Liang; Chun-Lin Wang
Journal:  J Zhejiang Univ Sci B       Date:  2018 Oct.       Impact factor: 3.066

8.  Psychometric properties of Power of Food Scale in Iranian adult population: gender-related differences in hedonic hunger.

Authors:  Fereshteh Aliasghari; Mohammad Asghari Jafarabadi; Neda Lotfi Yaghin; Reza Mahdavi
Journal:  Eat Weight Disord       Date:  2018-07-31       Impact factor: 4.652

9.  Striatal Dopamine D2 Receptors Regulate Cost Sensitivity and Behavioral Thrift.

Authors:  Devry Mourra; Federico Gnazzo; Steve Cobos; Jeff A Beeler
Journal:  Neuroscience       Date:  2019-12-03       Impact factor: 3.590

10.  Low Dopamine D2 Receptor Increases Vulnerability to Obesity Via Reduced Physical Activity, Not Increased Appetitive Motivation.

Authors:  Jeff A Beeler; Rudolf P Faust; Susie Turkson; Honggang Ye; Xiaoxi Zhuang
Journal:  Biol Psychiatry       Date:  2015-07-26       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.